Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06029491 · ClinicalTrials.gov registry record · NA
The Pivotal Study of RapidPulseTM Aspiration System
A NA study of Acute Ischemic Stroke, sponsored by RapidPulse.
- Recruiting
- Registry status
- NA
- Development phase
- 170
- Enrollment target
- 20
- Study locations
NCT06029491 is a NA study of Acute Ischemic Stroke that is actively recruiting participants, run by RapidPulse. The registered enrollment target is 170 participants, below the 345-participant average among 25 other Acute Ischemic Stroke trials with a reported enrollment target (51% lower). The trial reports 20 study locations across 15 states.
The verdict
NCT06029491, a NA study of Acute Ischemic Stroke, is actively recruiting participants, sponsored by RapidPulse.
- RECRUITING
- Registry status
- NA
- Development phase
- 170 participants
- Enrollment target
- 20
- Study locations
Study Summary
The goal of this clinical trials is to demonstrate the safety and effectiveness for the RapidPulseTM Aspiration System in patients experiencing acute ischemic stroke within 8 hours of symptom onset or last seen normal. Subjects will undergo mechanical thrombectomy (a procedure to remove a clot in the brain which is preventing blood flow), with the RapidPulseTM Aspiration System. Participation in the trial is for 90 days.
Conditions Studied
Interventions
- DEVICE RapidPulseTM Aspiration System
Study Locations (20)
Florida
- Baptist Health Research Institute - Jacksonville
- University of South Florida - Tampa
Illinois
- Rush University Medical Center - Chicago
- Advocate Aurora Research Institute - Park Ridge
New York
- State University of New York at Buffalo - Buffalo
- Icahn School of Medicine at Mount Sinai - New York
Tennessee
- Semmes Murphey Foundation - Baptist Memorial Hospital - Memphis
- Vanderbilt University Medical Center - Nashville
Other
- Centre Hospitalier Universitaire de Bordeaux - Bordeaux
- Centre Hospitalier Universitaire de Montpellier - Montpellier
California
- Providence Saint John's Medical Foundation - Torrance
Connecticut
- Yale University - New Haven
Georgia
- Emory University at Grady - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 170 participants |
| Start Date | 2025-03-27 |
| Est. Completion | 2027-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06029491
The ClinicalTrials.gov registry entry for NCT06029491 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 170 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 345-participant average among 25 other Acute Ischemic Stroke trials with a reported enrollment target (51% lower). The listed sponsor is RapidPulse, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Acute Ischemic Stroke appearing as the primary indexed condition, and to 1 intervention - of which RapidPulseTM Aspiration System is the first listed.
NCT06029491 reports 20 study locations spanning 15 distinct geographic areas - top geographies include Florida, Illinois, New York.
Frequently Asked Questions
What is clinical trial NCT06029491 about?
NCT06029491 is a clinical study titled "The Pivotal Study of RapidPulseTM Aspiration System". The goal of this clinical trials is to demonstrate the safety and effectiveness for the RapidPulseTM Aspiration System in patients experiencing acute ischemic stroke within 8 hours of symptom onset or last seen normal. Subjects will undergo mechanical thrombectomy (a procedure to remove a clot in th...
What is the current status of trial NCT06029491?
This trial is currently recruiting. It is a NA study. The enrollment target is 170 participants. The study started on 2025-03-27. Estimated completion is 2027-04.
What conditions does trial NCT06029491 study?
This clinical trial studies the following conditions: Acute Ischemic Stroke.
What interventions are being tested in trial NCT06029491?
The interventions under investigation include: RapidPulseTM Aspiration System (DEVICE).
Who is sponsoring clinical trial NCT06029491?
This trial is sponsored by RapidPulse, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06029491 being conducted?
This trial has 20 study locations across California, Connecticut, Florida, Georgia, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acute Ischemic Stroke
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Non-invasive Vagus Nerve Stimulation to Reduce Inflammation and Brain Injury Blood Biomarkers Following an Acute Ischemic Stroke
RECRUITING · NA
-
Hyperbaric Oxygen Therapy in Acute Ischemic Stroke Ischemic Stroke Recovery (Pro00061930)
RECRUITING · NA
-
An EFS to Evaluate the CGuard Prime™ Carotid Stent in Acute Ischemic Stroke
ACTIVE NOT RECRUITING · NA
-
Feasibility of a Digital Goals-of-Care Decision Aid for Clinicians and Families of Patients With SABI
ACTIVE NOT RECRUITING · NA
-
EndovaSCular TreAtment to imProve outcomEs for Medium Vessel Occlusions (ESCAPE-MeVO Trial)
ACTIVE NOT RECRUITING · NA
-
Solitaire™ With the Intention For Thrombectomy as PRIMary Endovascular Treatment (SWIFT PRIME) Trial
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.